Two models, one from Washington State and another from Los Angeles County, can be duplicated elsewhere to get people into care, experts say.
"Providing HCV treatment alone while neglecting to concurrently address the social determinants of health will do little to improve the health outcomes of the majority of individuals with chronic HCV," the study authors wrote.
Alternate PrEP guideline recommendations; partner notification and onward HIV transmission; shifting causes of death among HIV/HCV-coinfected people; correlates of lower adherence among people on methadone maintenance.
A cellphone attachment that detects HIV RNA; HIV-2 does indeed often progress to AIDS; CD4 count declines and incident hepatitis C coinfection; the global demographics of non-Hodgkin lymphoma.
It is estimated that one-third of Americans with hepatitis C pass through the criminal justice system each year.
Despite their increased risk, only one-third of adolescents and young adults with known opioid use disorder were screened for hepatitis C, according to a study released at the IDWeek conference in San Francisco.
A survey of 49 states reveals that an estimated 144,000 inmates with hepatitis C can't get the expensive drugs they need to cure it.
The recent steep increase in cases of acute hepatitis C virus infection, associated with increases in opioid injection, could have devastating long-term consequences.
The recent approval of a less expensive drug that generally cures hepatitis C in just eight weeks may make it easier for more insurers and correctional facilities to expand treatment.
"There are many interrelated epidemics within the 'opioid syndemic,'" Thomas J. Stopka writes. "Together, they make up perhaps the biggest public health challenge in the U.S. since the advent of the AIDS epidemic."